Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 9/20 | 0.32 |
| ▸ | NPY1R | P25929 | 5/20 | 0.32 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.32 |
| ▸ | NPY2R | P49146 | 3/20 | 0.32 |
| ▸ | NPY5R | Q15761 | 3/20 | 0.32 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.31 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.31 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14848974 | 0.90 | C3AR1 (0.34) | NPY4RNPY1RC3AR1ITGB3ITGA2B | |
| SCHEMBL14848982 | 0.82 | C3AR1 (0.39) | NPY4RNPY1RC3AR1ITGB3ITGA2B | |
| SCHEMBL18806927 | 0.82 | C3AR1 (0.36) | NPY4RNPY1RC3AR1ITGB3ITGA2B | |
| SCHEMBL14228397 | 0.80 | NPY4R (0.35) | NPY4RNPY1RC3AR1NPY2RNPY5R | |
| SCHEMBL19090970 | 0.80 | NPY4R (0.35) | NPY4RNPY1RC3AR1NPY2RNPY5R | |
| SCHEMBL9298017 | 0.79 | NPY4R (0.36) | NPY4RNPY1RC3AR1NPY2RNPY5R | |
| SCHEMBL14199839 | 0.79 | NPY4R (0.36) | NPY4RNPY1RC3AR1NPY2RNPY5R | |
| SCHEMBL4572695 | 0.77 | FOLH1 (0.36) | NPY4RNPY1RC3AR1NPY2RNPY5R | |
| SCHEMBL30493180 | 0.77 | FOLH1 (0.36) | NPY4RNPY1RC3AR1NPY2RNPY5R | |
| SCHEMBL4782556 | 0.77 | NPY4R (0.38) | NPY4RNPY1RC3AR1NPY2RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9932540-B2 | Method for refining lipid phases, and use | DREI LILIEN PVG GMBH & CO. KG (DE) | 2018-04-03 | — | — | US | disclosed |